In yesterday’s Wall Street session, Hims & Hers Health Inc (NYSE:HIMS) shares traded at $14.68, down -5.35% from the previous session.
HIMS stock price is now 19.78% away from the 50-day moving average and 67.40% away from the 200-day moving average. The market capitalization of the company currently stands at $3.15B.
With the price target maintained at $16, Imperial Capital recently Upgraded its rating from In-line to Outperform for Hims & Hers Health Inc (NYSE: HIMS). On February 26, 2024, Leerink Partners recently initiated its ‘Market Perform’ rating on the stock quoting a target price of $10, while ‘Imperial Capital’ rates the stock as ‘In-line’
In other news, Boughton Soleil, Chief Legal Officer sold 2,503 shares of the company’s stock on Apr 01 ’24. The stock was sold for $39,172 at an average price of $15.65. Upon completion of the transaction, the Chief Legal Officer now directly owns 166,866 shares in the company, valued at $2.45 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Mar 20 ’24, Chief Executive Officer Dudum Andrew sold 50,361 shares of the business’s stock. A total of $823,055 was realized by selling the stock at an average price of $16.34. A total of 35.26% of the company’s stock is owned by insiders.
During the past 12 months, Hims & Hers Health Inc has had a low of $5.65 and a high of $17.16. As of last week, the company has a debt-to-equity ratio of 0.03, a current ratio of 3.00, and a quick ratio of 2.74. The fifty day moving average price for HIMS is $12.26 and a two-hundred day moving average price translates $8.77 for the stock.
The latest earnings results from Hims & Hers Health Inc (NYSE: HIMS) was released for Dec, 2023. According to the Household & Personal Products Company, earnings per share came in at $0.01, beating analysts’ expectations of -$0.02 by 0.03. This compares to -$0.05 EPS in the same period last year. The net profit margin was -2.70% and return on equity was -7.18% for HIMS. The company reported revenue of $246.62 million for the quarter, compared to $167.2 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 47.5 percent. For the current quarter, analysts expect HIMS to generate $270.5M in revenue.
